THE PROJECT ALS MISSION
Project ALS identifies and funds the most promising scientific research that will lead to the first effective treatments and a cure for ALS. We recruit the world’s best scientists and doctors to work together—rationally and aggressively—to develop a better understanding of the ALS disease process and, in parallel, better therapeutic strategies.
Project ALS is the world’s first ALS organization to focus exclusively on research. We have raised over $100 million in 22 years to fund ALS research programs at leading academic institutions including Harvard University, Columbia University, UCSF, and the Salk Institute, and have made significant progress toward a cure for ALS.
Read about the latest updates and breakthroughs in ALS research, and see the Project ALS research philosophy – something we’re proud to say has accelerated the pace of research.
Spread the love💗Support Project ALS research when you make a purchase at now through Valentine’s Day! https://t.co/S5V5qRBXjoRead More
The core of THE CORE—its primary drug assessment platform—is the Kirchhoff Family Drug Screening Unit, where CORE researchers develop new cellular models of ALS & screen thousands of drug candidates on these ALS patient-derived lab models. Learn more: https://t.co/LfbiUvLXCvRead More
Tuesday's webinar features Neil Shneider, MD, PhD. Dr. Shneider is Director of the Eleanor and Lou Gehrig ALS Center at Columbia University, Co-Director of The Project ALS CORE, & the Claire Tow Associate Professor of Motor Neuron Disorders at Columbia. https://t.co/LQNFYmPmJrRead More